EMJ 10.3 2025

In this issue

We are delighted to share the third issue of EMJ for 2025. Featuring diverse content across multiple therapeutic areas, this issue focusing on advancements in genomics, an area with the potential to transform approaches disease prevention. Inside, we explore key topics in the field such as prostate cancer diagnosis, nivolumab in Hodgkin’s lymphoma, and phage therapy for acne vulgaris. This issue also includes interviews with Mark Caulfield, Bill Newman, and Stephen Kingsmore, who share exclusive insights from the forefront of the field.